Logo

Correlagen Partners with Children s Hospital Boston to Clinically Validate Genetic Tests

Sep 12, 2005

NEW YORK, Sept. 12 (GenomeWeb News) - Correlagen Diagnostics said today that it has signed a collaborative agreement with Children's Hospital Boston to explore the use of genetic testing in the clinic.

 

The partners intend to study the "clinical validity" of genetic diagnostics for certain diseases, and to discover correlations between genetic variation and disease phenotypes, the company said.

 

Correlagen said it will also provide sequence-based diagnostic assays to investigators at Children's Hospital for research purposes.

 

The company said it has the right to commercialize any diagnostic tests that arise from certain of these research programs.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.